Summary
The effects of prazosin, clonidine, and indoramin on central and regional hemodynamic parameters and left ventricular performance were analyzed in a congestive heart failure population to compare the pharmacodynamic responses to different levels of alpha-adrenergic interruption in this condition. The sympathetic nervous system is blocked at the peripheral alpha1-receptor by prazosin, at central nervous system alpha-receptor sites (via alpha-adrenoceptor agonism) by clonidine, and at peripheral and central sites by indoramin. Prazosin and indoramin produced reductions in total systemic and pulmonary vascular resistances, mean systemic and pulmonary artery pressures, and pulmonary capillary wedge pressure with little change in heart rate. Both agents selectively increased hepatic blood flow. Clonidine also decreased pulmonary artery pressure and vascular resistance, but evoked negative inotropic and chronotropic activity and did not alter regional blood flow. In contrast to prazosin, indoramin and clonidine did not augment cardiac output or stroke volume. In the setting of congestive heart failure, the central and regional hemodynamic effects and the responses in left ventricular performance vary considerably depending on the site of alpha-adrenergic interruption.
Similar content being viewed by others
References
Leier CV. Pharmacology and therapeutics of congestive heart failure.Rev Clin Basic Pharmacol 1985; 5:175–209.
Magorien RD, Triffon DW, Desch CE, et al. Prazosin and hydralazine in congestive heart failure: Regional hemodynamic effects in relation to dose.Ann Intern Med 1981; 95:5–13.
Hermiller JB, Magorien RD, Leithe ME, et al. Clonidine in congestive heart failure: A vasodilator with negative inotropic effects.Am J Cardiol 1983;51:791–795.
Leier CV, Huss P, Parrish D, et al. Preliminary observations of chronic indoramin therapy in congestive heart failure.J Cardiovasc Pharmacol 1986; 8:S112-S116.
Magorien RD, Hermiller JB, Unverferth DV, et al. Regional hemodynamic effects of clonidine in congestive heart failure.J Cardiovasc Pharmacol 1985; 7:91–96.
Leier CV, Binkley PF, Unverferth DV. Alpha1-adrenergic blockade redistributes cardiac output to the hepatic-splanchnic region in congestive heart failure: Regional hemodynamic studies with indoramin.Heart Failure 1986; Oct/Nov:231–235.
Leier CV, Magorien RD, Boudoulas H, et al. The effect of vasodilator therapy on systolic and diastolic time intervals in congestive heart failure.Chest 1982; 81:723–729.
Graham RM, Pettinger WA. Prazosin.N Engl J Med 1979; 300:232–236.
Rosendorff C. Alpha-adrenoreceptors in hypertension.J Cardiovasc Pharmacol 1986; 8(2):S3-S7.
Leier CV, Desch CE, Magorien RD, et al. Positive inotropic effects of hydralazine in human subjects: Comparison with prazosin in the setting of congestive heart failure.Am J Cardiol 1980; 46:1039–1044.
Awan NA, Miller RR, Miller M, et al. Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failure.Am J Med 1978; 65:146–160.
Desch CE, Magorien RD, Triffon DW, et al. Development of pharmacologic tolerance to prazosin in congestive heart failure.Am J Cardiol 1979; 44:1178–1183.
Lowenstein J. Clonidine.Ann Intern Med 1980; 92:74–77.
Hermiller JB, Magorien RD, Leithe ME, et al. Clonidine in congestive heart failure: A vasodilator with negative inotropic effects.Am J Cardiol 1983; 51:791–795.
Sharma JN, Sandrew BB, Wang SC. CNS site of clonidine induced hypotension: A microiontophoretic study of bulbar cardiovascular neurons.Brain Res 1978; 151:127–133.
Shanks RG. The clinical pharmacology of indoramin.J Cardiovasc Pharmacol 1986; 8:S8-S15.
Baum T, Shropshire AT. Central and peripheral contribution to the antihypertensive action of indoramin.Eur J Pharmacol 1975; 32:30–38.
Weissler AM, Harris WS, Schoenfeld CD. Systolic time intervals in heart failure in man.Circulation 1968; 37:149–159.
Lewis RP, Rittgers MS, Forester WF, et al. A critical review of the systolic time intervals.Circulation 1977; 56:146–157.
Leithe ME, Magorien RD, Hermiller JB, et al. Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure.Circulation 1984; 69:57–64.
Zelis R, Flaim S. Alterations in vasomotor tone in congestive heart failure.Prog Cardiovasc Dis 1982; 24:437–459.
Packer M, LeJemtel TH. Physiologic and pharmacologic determinants of vasodilator response: A conceptual framework for rational drug therapy for chronic heart failure.Prog Cardiovasc Dis 1982; 24:275–292.
Cotsamire DL, Unverferth DV, Leier CV. The relationship between drug-induced changes in central and regional hemodynamics in congestive heart failure.Can J Cardiol 1986; 2:272–277.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Good, A.P., Unverferth, D.V. & Leier, C.V. Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure. Cardiovasc Drug Ther 1, 529–534 (1988). https://doi.org/10.1007/BF02125736
Issue Date:
DOI: https://doi.org/10.1007/BF02125736